Wendy Rubinstein, whose experience includes overseeing precision medicine and human variation flagship resources including ClinVar at NIH’s National Center for Biotechnology Information (NCBI); experience building NIH’s Genetic Testing Registry (GTR), the world’s most comprehensive genetic test repository; and time serving as NIH’s Chief for Medical Genetics and Human Variation, NCBI, takes on a new challenges as Director for Personalized Medicine with the Food and Drug Administration.
Prior roles include:
- Deputy Medical Director, CancerLinQ – American Society of Clinical Oncology (ASCO)
- Chief, Medical Genetics and Human Variation, NCBI – National Institutes of Health
- Director, NIH Genetic Testing Registry and Senior Scientist – National Institutes of Health
